Dominic Allocco, MD, MS

Vice President, Clinical
Boston Scientific, Minnesota, United States

Dr. Dominic Allocco joined the Boston Scientific clinical team in July of 2006 and is currently Vice President of Clinical for the Cardiology division. His team is responsible for studies on coronary therapies, valvular heart disease and left atrial appendage closure. Dom received his BA in Economics from Harvard College and then received his MD from Stanford University. He also holds a MS in Engineering from Stanford University as well as a MS in Biomedical Informatics from the Massachusetts Institute of Technology. Dom completed residency training in Internal Medicine and fellowship training in Cardiology at Beth Israel Deaconess Medical Center in Boston. He is based in Minnesota.

Presentation(s):

• New Technologies to Reduce DRT

  Sunday, February 26, 2023
  3:59 PM – 4:07 PM ET

  Disclosure(s): Boston Scientific: Employee (Ongoing), Shareholder (Ongoing)

• Agent IDE ISR Trial

  Sunday, February 26, 2023
  2:32 PM – 2:38 PM ET

  Disclosure(s): Boston Scientific: Employee (Ongoing), Shareholder (Ongoing)

• Panel Discussion: Will DCB Play a Role for Coronary Application in the US?

  Sunday, February 26, 2023
  3:34 PM – 3:50 PM ET

  Disclosure(s): Boston Scientific: Employee (Ongoing), Shareholder (Ongoing)

• Panel Discussion: Treatment of Aortic Insufficiency | The Next Frontier

  Monday, February 27, 2023
  3:47 PM – 4:10 PM ET

  Disclosure(s): Boston Scientific: Employee (Ongoing), Shareholder (Ongoing)

• Global Trial Challenges and Opportunities: An Industry Perspective

  Monday, February 27, 2023
  4:34 PM – 4:42 PM ET

  Disclosure(s): Boston Scientific: Employee (Ongoing), Shareholder (Ongoing)

• Panel Discussion and Question

  Monday, February 27, 2023
  4:42 PM – 5:05 PM ET

  Disclosure(s): Boston Scientific: Employee (Ongoing), Shareholder (Ongoing)

• Panel Discussion: Leveraging Real World Evidence: Where Are We Now and What Lies Ahead?

  Tuesday, February 28, 2023
  10:07 AM – 10:30 AM ET

  Disclosure(s): Boston Scientific: Employee (Ongoing), Shareholder (Ongoing)

• Panel Discussion: Digital Heath Apps in Clinical Trials: Ready for Prime Time?

  Tuesday, February 28, 2023
  10:55 AM – 11:25 AM ET

  Disclosure(s): Boston Scientific: Employee (Ongoing), Shareholder (Ongoing)

• The Neo ACCURATE 2: Next-Generation Improvements and Design Features

  Tuesday, February 28, 2023
  9:14 AM – 9:22 AM ET

  Disclosure(s): Boston Scientific: Employee (Ongoing), Shareholder (Ongoing)

• Panel Discussion | Second- and Third-Generation Aortic Valve Systems not Approved in the US Yet

  Tuesday, February 28, 2023
  10:18 AM – 10:30 AM ET

  Disclosure(s): Boston Scientific: Employee (Ongoing), Shareholder (Ongoing)

• LAA Closure Beyond the WATCHMAN FLX: Design Modifications and How to Reduce DRT

  Tuesday, February 28, 2023
  10:38 AM – 10:46 AM ET

  Disclosure(s): Boston Scientific: Employee (Ongoing), Shareholder (Ongoing)